News

Filter by Category

Filter by Program

Filter by Publish Date

CPTA Welcomes Triplet Therapeutics Chief Medical Officer as Industry Co-Director

C-Path’s Critical Path to Therapeutics for the Ataxias Consortium is pleased to announce the appointment of Irina Antonijevi

C-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its firs

C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science

Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a

C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera

C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr

The Critical Path Institute Data Collaboration Center is seeking proposals for the creation of non-identifiable, synthetic patient

C-Path has signed a Memorandum of Understanding with EATRIS, the European infrastructure for translational medicine, to accelerate

C-Path’s Patient-Reported Outcome (PRO) Consortium announced that it has been awarded a U.S. Food and Drug Administration (FDA)

C-Path’s Patient-Reported Outcome (PRO) Consortium announced today it has been awarded a U.S. Food and Drug Administratio